Mydecine Innovations Group, Inc. (TSE:MYCO) has released an update.
Mydecine Innovations Group Inc. has successfully settled its debts with two creditors by issuing over 3.6 million common shares, easing the company’s financial obligations. The shares, valued at $0.017 each, will commence trading on the Aquis Stock Exchange around April 18, 2024. This move is part of the company’s strategic efforts to manage its capital structure and maintain a healthy balance sheet.
For further insights into TSE:MYCO stock, check out TipRanks’ Stock Analysis page.
